Skip to main content

Table 4 Stability of four analytes in dog plasma (n = 3)

From: Pharmacokinetic study of the main components of Tanreqing capsules and Tanreqing injections in beagles by liquid chromatography–tandem mass spectrometry

Analyte

Nominal concentration

(ng/mL)

Short-term stability

(6 h at room temperature)

Long-term stability

(30 days at – 80 °C)

Freeze-thaw stability

(3 cycles)

Mean ± S.D

concentration

(ng/mL)

RSD

(%)

Mean ± S.D. concentration

(ng/mL)

RSD

(%)

Mean ± S.D. concentration

(ng/mL)

RSD

(%)

Baicalin

4

4.01 ± 0.31

7.75

3.50 ± 0.07

2.00

3.97 ± 0.36

9.12

20

18.43 ± 0.75

4.05

17.47 ± 0.42

2.42

17.88 ± 0.92

5.13

200

182.83 ± 7.72

4.22

175.01 ± 4.57

2.61

202.81 ± 10.87

5.36

Ursodeoxycholic acid

20

19.38 ± 0.97

5.01

18.77 ± 0.41

2.20

18.47 ± 1.66

9.00

100

97.83 ± 0.62

0.63

90.80 ± 1.57

1.73

87.08 ± 1.95

2.24

1000

1104.46 ± 16.75

1.52

1081.75 ± 20.70

1.91

1048.41 ± 75.10

7.16

Chenodeoxycholic acid

2

1.77 ± 0.06

3.21

1.92 ± 0.22

11.27

1.97 ± 0.17

8.89

10

9.79 ± 0.78

7.94

10.10 ± 0.36

3.54

9.37 ± 0.95

10.16

100

101.57 ± 0.54

0.53

101.23 ± 5.13

5.07

95.70 ± 4.66

4.87

Chlorogenic acid

2

1.98 ± 0.16

8.27

1.73 ± 0.05

3.00

2.07 ± 0.17

8.16

10

8.97 ± 0.70

7.75

8.95 ± 0.42

4.65

10.03 ± 0.84

8.33

100

88.28 ± 2.72

3.08

87.31 ± 4.62

5.30

95.65 ± 3.72

3.89